Dr. Martens PLC

Board/Management Information • Jun 3, 2024

National Storage Mechanism | Additional information

RNS Number : 6934Q

Dr. Martens PLC

03 June 2024

3 June 2024

Dr. Martens plc

Company Secretary Appointment

Dr. Martens plc (the "Company") announces that Katherine Bellau has been appointed as Company Secretary with effect from today, 3 June 2024. Katherine succeeds Emily Reichwald, who will be taking up a different role within the business.

Enquiries

Investors and analysts                                                                       

Bethany Barnes, Director of Investor Relations                Bethany.Barnes@drmartens.com                     +44 7825 187465

Beth Callum, Investor Relations Manager                        Beth.Callum@drmartens.com                           +44 203 995 2644

Press                                                                                                                                                    

H/Advisors Maitland                                                                                                                                        +44 207 379 5151

Katharine Spence                                                                                                                                              +44 7384 535739

Gill Hammond, Director of Communications                                                                                                   +44 7384 214248

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Produced originally for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DM's" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

COSEAFSFDSSLEFA